аЯрЁБс>ўџ 68ўџџџ5џџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџьЅСo@№Пє%bjbj p p .(ooУ џџџџџџˆжжжжжжжъ. ъOЖFFFFFFFF†ˆˆˆˆˆˆ$RW BЌ]жFFFFFЌжжFF ъъъF2жFжF†ъF†ъ(ъжжF: =Я ЊЎЧxRr0O™ Ъ ™ ъъжжжж™ ж`FFъFFFFFЌЌъъю$дъъю AMYLOID CASCADE HYPOTHESIS: IS IT TRUE FOR SPORADIC ALZHEIMER S DISEASE? M. `alkovi-Petriai, E. Grќnblatt, J. Osmanovi, S. Hoyer, P. Riederer Huge progress in understanding and treating of Alzheimer's disease (AD) has started whith the era of AD modeling. However, experimental model that recapitulates all aspects of Alzheimer's disease (AD) has not yet been produced although various transgenic mouse lines have been designed that offer relatively faithful reproductions of some of the main neuropathologicall features; extracellular senile plaques composed of unsoluble amyloid beta (AВ) fibrilles, and intraneuronal neurofibrillary tangles composed of hyperphosphorylated form of microtubule associated protein tau. Currently, the leading hypothesis assumes that pathological assemblies of AВ are the cause of all forms of AD, whereas other neuropathological changes are downstream consequences of pathological AВ accumulation. However, this hypothesis fits only to the familial, early onset type of AD caused by mutations in three particular AВ-related genes, while the great majority of AD patients have sporadic late-onset type of disease (sAD) with age and several susceptibility genes as risk factors. In line with the brain insulin dysfunction found post-mortem in sAD patients, streptozotocin-intracerebroventricularly treated rats (STZ-icv) have been recently proposed as an experimental model for sAD because STZ is a drug selectively toxic for insulin producing/secreting cells. Central, icv application of STZ is associated with progressive deficits in learning and memory, decrement in cholinergic transmission and decreased glucose and energy metabolism in the brain. To further characterize this model we investigated the brain insulin system and influence of its dysfunction on tau protein and amyloid beta (AВ) peptide following STZ-icv administration. Gene expression of insulin and insulin receptor (IR), alterations of IR-beta subunit, IR tyrosine kinase (TK) activity, expression of protein kinase B (Akt/PKB), glycogen synthase kinase 3 (GSK-3) and tau protein were measured by RT-PCR, ELISA, TK assay and Western blot in frontoparietal cortex (CTX) and hippocampus (HPC) of adult STZ-icv (1 mg/kg) treated rats. 8<R”–Тњ( , Š М Ф д  C F [ ] ƒ Ё Г С Т У ф я  РюіHTZ€Ф ј№ш№рйейШПЖП­ПЄ›П›П›­П›П›П­ŽŽp_p_p_!hxghЛ/йB*aJmH phsH !hxghЖ'xB*aJmH phsH hxghЛ/йaJmH sH hxghЖ'xaJmH sH hxghnKaJhxghXЌaJhxghˆ aJhxgh’DaJhxgh•x'aJhxghЂ}ЦaJmHsHhxg hЋ\{hЂ}ЦhЂ}ЦmH sH hxgmH sH hXcqmH sH hрfџmH sH %–& ( |V#€%є%яяяллЧЧЧ$ Ц,„А„А]„А^„Аa$gd0H$ Ц,„А„А]„А^„Аa$gdxg$„А„А]„А^„Аa$gdЂ}Цє%ў 4mo™Л’Фz€@!B!D!F!ј!њ!$#T#V#Z#z#Š#˜#ђ#$$$~%„%юнюнЯОЯОЕЌЕІЂ›™›ЂŽ›Ž›Ž›Ž{wpipibwbiw h0Hh0H h0HhXЌ h0Hhxgh0H h0HaJh0HhXЌaJmH sH hxghXЌmH sH U hxghXЌhxg hxgaJhxghxgaJhxghXЌaJ!hxgh’DB*aJmH phsH hxgB*aJmH phsH !hxghЛ/йB*aJmH phsH !hxghЖ'xB*aJmH phsH $AВ aggregates were visualised by Congo red staining. Cognitive deficits were measured in Morris Water Maze Test. Data were analysed by Cruscal-Walles ANOVA and Mann-Whitney U test (P<0.05). Expression of insulin-1 (HPC) and -2 (CTX) and IR mRNA (CTX, HPC) was decreased. Phosphorylated IR-beta subunit content was increased (CTX) and TK activity increased (HPC). Akt/PKB and phosphorylated/non-phosphorylated GSK-3Б/В ratio were decreased (HPC) GSK-3-related hyperphosphorylation of tau protein (HPC) and AВ aggregates in meningeal capillaries were found not earlier than 3 months after STZ-icv treatment. Cognitive deficits were found as early as 2 weeks after STZ-icv treatment. Results support STZ-icv rat as a representative experimental sAD model which suggests that instead of AВ, imbalance in IR signaling cascade phosphorylation/dephosphorylation and insulin resistant brain state could be the primary pathological event in sAD ethiopathogenesis. Supported by Croatian MZOS (108-1080003-0020) and DAAD. „%ђ%є%ѕьh0HhXЌaJh0HhXЌmH sH ,1hА‚. АЦA!А‰"А‰#‰$n%ААФАФ Фœ@@ёџ@ Ђ}ЦNormalCJ_HaJmHsHtHDA@ђџЁD Default Paragraph FontRi@ѓџГR  Table Normalі4ж l4жaі (k@єџС(No List>B@ђ> Ђ}Ц Body TextaJmHsHtH*W`Ђ* XЌStrong5\6U`Ђ6 Ж'x Hyperlink >*B*phџУ (џџџџK“”Z‡ t ‰ Х ˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€˜0€€Х š0€€ЁB} „%є% є% є% KLN_`“–]_ГДЩЪя№и"$Uf›!ƒ†9LOŠцщJU67W\vwЈЉвдYZmnЧЩ! " } ~ † Л П к ш 6 9 B c i j k l – Њ Ў Б Х Ц е о   e h v Т У Ы Ь ˆ Х K’–иY\† v ˆ ‹ Т Х 3Х У Ы Х џџMelita SalkovicхxgЂ2H/ ˆ •x'r=’D0HnK=P­\XcqЖ'xXЌЂ}ЦЛ/йЃRёрfџУ Х џ@€Ы Ы фю˜SSЫ Ы XTTTTЩУ €€@€ € @€€(@€џџUnknownџџџџџџџџџџџџGю‡z €џTimes New Roman5€Symbol3&ю ‡z €џArial"qŒ№ФЉЊ ЖІрtЖ† Лчм чм !№‰‰ДД24Н Н  3ƒq№H)№џ?тџџџџџџџџџџџџџџџџџџџџџ=PџџnALTERED EXPRESSION OF INSULIN RECEPTOR IN HIPPOCAMPUS OF STREPTOZOTOCIN INTRACEREBROVENTRICULLARY TREATED RATSMelita SalkovicMelita Salkovicўџр…ŸђљOhЋ‘+'Гй0р˜4@L\ t€ œ Ј ДРШаитoALTERED EXPRESSION OF INSULIN RECEPTOR IN HIPPOCAMPUS OF STREPTOZOTOCIN INTRACEREBROVENTRICULLARY TREATED RATSLTEMelita SalkovicelieliNormalSMelita Salkovic9liMicrosoft Word 10.0@"Є@ќ<И(ЄЧ@ЈтщЉЎЧчм ўџеЭеœ.“—+,љЎ0h hpŒ”œЄ ЌДМФ Ь GтMedicinski fakultetН { oALTERED EXPRESSION OF INSULIN RECEPTOR IN HIPPOCAMPUS OF STREPTOZOTOCIN INTRACEREBROVENTRICULLARY TREATED RATS Title ўџџџўџџџ !"#$ўџџџ&'()*+,ўџџџ./01234ўџџџ§џџџ7ўџџџўџџџўџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџRoot Entryџџџџџџџџ РF№р ЊЎЧ9€Data џџџџџџџџџџџџ1TableџџџџWordDocumentџџџџ.(SummaryInformation(џџџџџџџџџџџџ%DocumentSummaryInformation8џџџџџџџџ-CompObjџџџџџџџџџџџџjџџџџџџџџџџџџўџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџўџ џџџџ РFMicrosoft Word Document MSWordDocWord.Document.8є9Вq